Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Karim I. Budhwani"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Colorectal cancer (CRC) is a highly prevalent and lethal cancer worldwide. Approximately 45% of CRC patients harbor a gain-in-function mutation in KRAS. KRAS is the most frequently mutated oncogene accounting for approximately 25% of all human cancer
Externí odkaz:
https://doaj.org/article/b8b756094a9d42089d0c4751ec0c101a
Publikováno v:
Micromachines, Vol 11, Iss 7, p 687 (2020)
Walking on water is made possible, at least for tiny insects, by molecular interaction at the interfaces of dissimilar materials. Impact of these interactions—surface tension (SFT) and, more broadly, interfacial tension (IFT)—is particularly evid
Externí odkaz:
https://doaj.org/article/6235b7cf4c3b4e0e86947d21cdd4eeab
Publikováno v:
Trends in Biotechnology. 40:1361-1373
Cancer is a complex and uniquely personal disease. More than 1.7 million people in the United States are diagnosed with cancer every year. As the burden of cancer grows, so does the need for new, more effective therapeutics and for predictive tools t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c986a5c75d54485b12f7215cee64ae
https://doi.org/10.1016/j.tibtech.2022.04.003
https://doi.org/10.1016/j.tibtech.2022.04.003
Autor:
Saleem Sayani, Munir Ghesani, Karim I. Budhwani, Aliyah R. Sohani, Zohray Talib, Gurudatta Naik, Sheemain Asaria, Shahin Sayed, Anne Mwirigi, Asim Jamal Shaikh, Zahir Moloo, Mansoor N. Saleh
Publikováno v:
Current Breast Cancer Reports. 11:158-169
As medical knowledge and innovation reaches new heights, there is a growing gap in medical advancements between low- and middle-income countries (LMICs) and high-income countries (HICs). The former has lack of basic health care and preventive or diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec9f595e565666ce157bec98defa8fb5
https://doi.org/10.1007/s12609-019-00322-6
https://doi.org/10.1007/s12609-019-00322-6
UNSTRUCTURED This is the author response to peer review.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fcc7e769572629982ec4f0308a8f39c
https://doi.org/10.2196/preprints.27258
https://doi.org/10.2196/preprints.27258
Autor:
Heli K. Patel, Zeenia Punjani, Areesha A. Charania, Zeelu H. Patel, Georgios Papachristou, Carlo M. Contreras, Allan Tsung, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13502-e13502
e13502 Background: Nearly half the world will be diagnosed with cancer. Each year, > 1.7 million new cancers are diagnosed in the US. Worse, systemic therapy turns out to be ineffective in 70% of patients because those drugs do not match the patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f7aa5fa7ed9f3089080809587876b59
https://doi.org/10.1200/jco.2022.40.16_suppl.e13502
https://doi.org/10.1200/jco.2022.40.16_suppl.e13502
Autor:
Areesha A. Charania, Heli K. Patel, Zeenia Punjani, Zeelu H. Patel, Georgios Papachristou, Carlo M. Contreras, Allan Tsung, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13501-e13501
e13501 Background: Nearly 70% of diagnostics lab test errors occur due to variability in preanalytical factors. Preanalytical factors comprise parameters from the time tissue is extracted from the patient to the time it is tested in the lab. For lack
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eb30ba440dd1e82e10e80021cb16a8f
https://doi.org/10.1200/jco.2022.40.16_suppl.e13501
https://doi.org/10.1200/jco.2022.40.16_suppl.e13501
Autor:
Zeenia Punjani, Zeelu H. Patel, Areesha A. Charania, Heli K. Patel, Georgios Papachristou, Carlo M. Contreras, Allan Tsung, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13503-e13503
e13503 Background: Despite advances in high-throughput screening, combinatorial chemistry, databanks, and computational models, drug R&D remains expensive and slow, often over a decade. It is estimated that pre-human costs are > 30% of cost of approv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eb4ea4b7f0f4bfb422e8403dbbf210a
https://doi.org/10.1200/jco.2022.40.16_suppl.e13503
https://doi.org/10.1200/jco.2022.40.16_suppl.e13503
Autor:
Zeelu H. Patel, Areesha A. Charania, Zeenia Punjani, Heli K. Patel, Mary Kathryn Sewell-Loftin, Mansoor N. Saleh, Karim I. Budhwani
Publikováno v:
Journal of Clinical Oncology. 40:e13500-e13500
e13500 Background: Despite recent advances in therapeutics, cancer remains the second leading cause of death worldwide. Next generation cancer models hold the promise of breaking this stranglehold. However, extracting adequate tissue for precision an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a204c341dcc1f67825eed528393a368
https://doi.org/10.1200/jco.2022.40.16_suppl.e13500
https://doi.org/10.1200/jco.2022.40.16_suppl.e13500
SARS-CoV-2 transmission risk generally increases with proximity of those shedding the virus to those susceptible to infection. Thus, this risk is a function of both number of people and the area which they occupy. However, the latter continues to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300afcf2be689235ce028d5f842e4149